Crossmark

Multicentre, open-label, phase IV, randomised trial testing superiority of individualised targeted antibiotic prophylaxis over empiric prophylaxis at ureteral stent removal following cystectomy: study protocol for the REINFORCE trial

Crossref DOI link: https://doi.org/10.1186/s13063-025-08981-w

Published Online: 2025-07-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vejlgaard, Maja https://orcid.org/0000-0001-6907-2609
Stroomberg, Hein Vincent

Ynddal, Mie Skjøttgaard

Moser, Claus

Joensen, Ulla Nordström

Røder, Andreas
Funding

Funding for this research was provided by:

Copenhagen University
License Information

Text and Data Mining valid from 2025-07-28

Version of Record valid from 2025-07-28
More Information

Article History

Received: 21 January 2025

Accepted: 10 July 2025

First Online: 28 July 2025

Declarations

:

: This trial was approved by the Danish Medicines Agency and the Danish Medical Research Ethics Committee through the European Clinical Trials Information System on December 10th, 2024 (EU CT 2024-514312-27-00). All trial participants will sign an informed consent before any trial procedures begin and will be informed of their right to withdraw at any point without explanation.

: The informed consent will include information of publication of the trial results, which will all be anonymous.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below